Previous work identified an increase in SPP24 protein was able to discriminate between IBD and control patients and increasing amounts of SPP24 peptide correlated with an increase in the severity of symptoms- separating those in clinical remission18. The gene discussed is SPP2; the disease is irritable bowel syndrome.